Silence Therapeutics PLC(SLN) - 2024 Q4 - Annual Results

Exhibit 99.1 Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update The Company's cash guidance is now extended into 2027 Company to host conference call and webcast today at 8 a.m. EST / 1 p.m. GMT 27 February 2025 LONDON, Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today reported its financial results for the full year ended December 31, 2024, and provided a ...